Surgeon-Guided Serratus Block in Breast Reduction Surgery

NCT ID: NCT06905574

Last Updated: 2026-01-29

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-12-01
• Study Completion Date: 2025-10-31

Brief Summary

Surgeon guided serratus block, which can be performed by the surgeon in participants undergoing breast reduction surgery, may reduce the sensation of pain from the surgical field in the postoperative period. Thus, participants experience less pain in the postoperative period, consume less analgesics, and there is a decrease in related complications. The aim of this study was to evaluate the effects of the intraoperative surgeon guided serratus block applied on the analgesic consumption of the participants in the first 24 hours after surgery in participants undergoing breast reduction surgery.

Conditions

Postoperative Pain Control; Breast Reduction

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: OTHER
• Blinding Strategy: SINGLE

Study Groups

Group Control

No intervention will be made in this group.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Group SSPB

Surgeon guided serratus block will be applied before closing dermoglandular flaps

Group Type: EXPERIMENTAL

surgeon guided serratus block

Intervention Type: OTHER

Surgeon guided Serratus Block will be applied before closing dermoglandular flaps

Interventions

surgeon guided serratus block

Surgeon guided Serratus Block will be applied before closing dermoglandular flaps

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patient's willingness to be included in the study
• 18-65 years
• Woman
• Operated with inferior pedicled breast reduction technique
• The distance from the sternal notch to the nipple complex is between 25-40cm
• ASA I-II
• Breast Usg result BIRADS 1-2
• Patients who have not previously received RT to the breast and have no history of malignancy

Exclusion Criteria

• Patient's request/refusal not to be included in the study
• Previous history of malignancy
• RT story,
• ASA 3-4-5-patient group
• Severe organ failure
• Alcohol, drug addiction
• Bupivacaine allergy
• Diagnosis of psychiatric illness and psychiatric drug use
• Surgery lasting longer than 3 hours
• Bleeding diathesis

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

alperen can kokten

OTHER

Sponsor Role: lead

Responsible Party

alperen can kokten

doctor faculty member

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Ayhan Sönmez

Role: STUDY_DIRECTOR

SAMSUN UNİVERSİTY

Locations

Samsun training and research hospital

Samsun, , Turkey (Türkiye)

Countries

Turkey (Türkiye)

Other Identifiers

SamsunU

Identifier Type: OTHER

Identifier Source: secondary_id

SGSB-01

Identifier Type: -

Identifier Source: org_study_id